BG
ATYR

BlackRock Group’s aTyr Pharma ATYR Stock Holding History

BlackRock Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$36K Hold
1,180
– – ﹤0.01% 2937
2016
Q3 		$53K Hold
1,180
– – ﹤0.01% 2906
2016
Q2 		$46K Buy
+1,180
New +$54.9K ﹤0.01% 2931

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

BlackRock Group's ATYR Position: Q4 2016 in Review

BlackRock Group held its aTyr Pharma (ATYR) position steady in Q4 2016 at 1,180 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

BlackRock Group first reported a position in ATYR in Q2 2016 and has held it in 3 quarters since. The position peaked at $53K in Q3 2016. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

  • BlackRock Group held 1,180 shares of aTyr Pharma worth $36K as of Q4 2016.
  • BlackRock Group left its aTyr Pharma share count unchanged in Q4 2016.
  • aTyr Pharma made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2937 holding.
  • BlackRock Group first reported a position in aTyr Pharma in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Group's aTyr Pharma position peaked at $53K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.